- Home
- BNZI vs SILO Comparison
BNZI vs SILO Comparison
Compare BNZI & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNZI
- SILO
- Stock Information
- Founded
- BNZI 2016
- SILO 2010
- Country
- BNZI United States
- SILO United States
- Employees
- BNZI N/A
- SILO N/A
- Industry
- BNZI
- SILO Apparel
- Sector
- BNZI
- SILO Consumer Discretionary
- Exchange
- BNZI Nasdaq
- SILO Nasdaq
- Market Cap
- BNZI 8.9M
- SILO 8.8M
- IPO Year
- BNZI N/A
- SILO N/A
- Fundamental
- Price
- BNZI $1.64
- SILO $1.61
- Analyst Decision
- BNZI Strong Buy
- SILO
- Analyst Count
- BNZI 1
- SILO 0
- Target Price
- BNZI $125.00
- SILO N/A
- AVG Volume (30 Days)
- BNZI 4.5M
- SILO 9.1M
- Earning Date
- BNZI 02-28-2025
- SILO 02-14-2025
- Dividend Yield
- BNZI N/A
- SILO N/A
- EPS Growth
- BNZI N/A
- SILO N/A
- EPS
- BNZI N/A
- SILO N/A
- Revenue
- BNZI $4,310,782.00
- SILO $72,102.00
- Revenue This Year
- BNZI $5.58
- SILO $1.86
- Revenue Next Year
- BNZI $58.87
- SILO N/A
- P/E Ratio
- BNZI N/A
- SILO N/A
- Revenue Growth
- BNZI N/A
- SILO N/A
- 52 Week Low
- BNZI $1.21
- SILO $0.77
- 52 Week High
- BNZI $80.00
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- BNZI 53.10
- SILO 53.40
- Support Level
- BNZI $1.57
- SILO $1.50
- Resistance Level
- BNZI $2.70
- SILO $1.89
- Average True Range (ATR)
- BNZI 0.26
- SILO 0.20
- MACD
- BNZI 0.05
- SILO -0.04
- Stochastic Oscillator
- BNZI 37.58
- SILO 28.81
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.